Cargando…
Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors
[Image: see text] Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein–ligand recognition and improving...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344462/ https://www.ncbi.nlm.nih.gov/pubmed/35737472 http://dx.doi.org/10.1021/acs.jmedchem.1c02012 |
_version_ | 1784761225743171584 |
---|---|
author | Burastero, Osvaldo Defelipe, Lucas A. Gola, Gabriel Tateosian, Nancy L. Lopez, Elias D. Martinena, Camila Belen Arcon, Juan Pablo Traian, Martín Dodes Wetzler, Diana E. Bento, Isabel Barril, Xavier Ramirez, Javier Marti, Marcelo A. Garcia-Alai, Maria M. Turjanski, Adrián G. |
author_facet | Burastero, Osvaldo Defelipe, Lucas A. Gola, Gabriel Tateosian, Nancy L. Lopez, Elias D. Martinena, Camila Belen Arcon, Juan Pablo Traian, Martín Dodes Wetzler, Diana E. Bento, Isabel Barril, Xavier Ramirez, Javier Marti, Marcelo A. Garcia-Alai, Maria M. Turjanski, Adrián G. |
author_sort | Burastero, Osvaldo |
collection | PubMed |
description | [Image: see text] Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein–ligand recognition and improving molecular docking predictions. In this work, we used ethanol as a cosolvent to find relevant interactions for ligands toward protein kinase G, an essential protein of Mycobacterium tuberculosis (Mtb). We validated the hot spots by screening a database of fragment-like compounds and another one of known kinase inhibitors. Next, we performed a pharmacophore-guided docking simulation and found three low micromolar inhibitors, including one with a novel chemical scaffold that we expanded to four derivative compounds. Binding affinities were characterized by intrinsic fluorescence quenching assays, isothermal titration calorimetry, and the analysis of melting curves. The predicted binding mode was confirmed by X-ray crystallography. Finally, the compounds significantly inhibited the viability of Mtb in infected THP-1 macrophages. |
format | Online Article Text |
id | pubmed-9344462 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-93444622022-08-03 Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors Burastero, Osvaldo Defelipe, Lucas A. Gola, Gabriel Tateosian, Nancy L. Lopez, Elias D. Martinena, Camila Belen Arcon, Juan Pablo Traian, Martín Dodes Wetzler, Diana E. Bento, Isabel Barril, Xavier Ramirez, Javier Marti, Marcelo A. Garcia-Alai, Maria M. Turjanski, Adrián G. J Med Chem [Image: see text] Computer-aided drug discovery methods play a major role in the development of therapeutically important small molecules, but their performance needs to be improved. Molecular dynamics simulations in mixed solvents are useful in understanding protein–ligand recognition and improving molecular docking predictions. In this work, we used ethanol as a cosolvent to find relevant interactions for ligands toward protein kinase G, an essential protein of Mycobacterium tuberculosis (Mtb). We validated the hot spots by screening a database of fragment-like compounds and another one of known kinase inhibitors. Next, we performed a pharmacophore-guided docking simulation and found three low micromolar inhibitors, including one with a novel chemical scaffold that we expanded to four derivative compounds. Binding affinities were characterized by intrinsic fluorescence quenching assays, isothermal titration calorimetry, and the analysis of melting curves. The predicted binding mode was confirmed by X-ray crystallography. Finally, the compounds significantly inhibited the viability of Mtb in infected THP-1 macrophages. American Chemical Society 2022-06-23 2022-07-28 /pmc/articles/PMC9344462/ /pubmed/35737472 http://dx.doi.org/10.1021/acs.jmedchem.1c02012 Text en © 2022 American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Burastero, Osvaldo Defelipe, Lucas A. Gola, Gabriel Tateosian, Nancy L. Lopez, Elias D. Martinena, Camila Belen Arcon, Juan Pablo Traian, Martín Dodes Wetzler, Diana E. Bento, Isabel Barril, Xavier Ramirez, Javier Marti, Marcelo A. Garcia-Alai, Maria M. Turjanski, Adrián G. Cosolvent Sites-Based Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors |
title | Cosolvent Sites-Based
Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors |
title_full | Cosolvent Sites-Based
Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors |
title_fullStr | Cosolvent Sites-Based
Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors |
title_full_unstemmed | Cosolvent Sites-Based
Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors |
title_short | Cosolvent Sites-Based
Discovery of Mycobacterium Tuberculosis Protein Kinase G Inhibitors |
title_sort | cosolvent sites-based
discovery of mycobacterium tuberculosis protein kinase g inhibitors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344462/ https://www.ncbi.nlm.nih.gov/pubmed/35737472 http://dx.doi.org/10.1021/acs.jmedchem.1c02012 |
work_keys_str_mv | AT burasteroosvaldo cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT defelipelucasa cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT golagabriel cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT tateosiannancyl cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT lopezeliasd cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT martinenacamilabelen cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT arconjuanpablo cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT traianmartindodes cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT wetzlerdianae cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT bentoisabel cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT barrilxavier cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT ramirezjavier cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT martimarceloa cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT garciaalaimariam cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors AT turjanskiadriang cosolventsitesbaseddiscoveryofmycobacteriumtuberculosisproteinkinaseginhibitors |